Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Oncology Pharma Inc.
Oncology Pharma Inc. News
Oct 15, 2021 - accesswire.com
Oncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior Listing
Sep 13, 2021 - accesswire.com
Oncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug Product
Oncology Pharma Inc. Quantitative Score
About Oncology Pharma Inc.
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Oncology Pharma Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Oncology Pharma Inc. Financials
Table Compare
Compare ONPH metrics with: | |||
|---|---|---|---|
Earnings & Growth | ONPH | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | ONPH | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | ONPH | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | ONPH | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Oncology Pharma Inc. Income
Oncology Pharma Inc. Balance Sheet
Oncology Pharma Inc. Cash Flow
Oncology Pharma Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Oncology Pharma Inc. Executives
| Name | Role |
|---|---|
| Mr. Chuck Wagner | President, Treasurer & Chairman |
| Mr. George Malesek | Interim Chief Executive Officer |
| Mr. Dimitri Theofilopolous Esq. | Legal Counsel |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Chuck Wagner | President, Treasurer & Chairman | Male | -- | |
| Mr. George Malesek | Interim Chief Executive Officer | Male | -- | |
| Mr. Dimitri Theofilopolous Esq. | Legal Counsel | Male | -- |